Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

309.33
Delayed Data
As of 3:59pm ET
 -8.84 / -2.78%
Today’s Change
223.02
Today|||52-Week Range
333.65
+0.97%
Year-to-Date
Biotech Stock Roundup: Medivation to Pfizer, Clovis Priority Review
2:55pm / Zacks.com - Paid Partner Content
Ionis Pharmaceuticals Inc Begins to Shift Focus
Aug 16 / MotleyFool.com - Paid Partner Content
Biotechs Rally on Pfizer/Medivation Deal
Aug 22 / TheStreet.com - Paid Partner Content
Top 3 Research Reports for August 15, 2016
Aug 15 / Zacks.com - Paid Partner Content
9 Stocks Smart Investors Put Their Money in Last Quarter
Aug 20 / TheStreet.com - Paid Partner Content
Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline
Aug 15 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Aug 17 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Regeneron, BioMarin, AbbVie, Amgen and Biogen
Aug 12 / Zacks.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Earnings in Focus, AbbVie Takes Steps to Block Humira Copycat
Aug 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close318.17
Today’s open318.18
Day’s range306.73 - 321.74
Volume1,646,520
Average volume (3 months)1,917,864
Market cap$69.7B
Dividend yield--
Data as of 3:59pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+16.25%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)-3.87%
P/E ratio18.1
Price/Sales7.60
Price/Book7.42

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.97-1.19%
BAXBaxter International...-0.92-1.92%
ILMNIllumina Inc-3.25-1.88%
AMGNAmgen-3.56-2.04%
Data as of 4:02pm ET, 08/24/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)$5.00
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs